Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
-
Therapeutic Areas
Our expertise in the industry
More than 20+ drugs by leading pharma players including Novartis, Sanofi, and others received FDA approval ...
Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative potential as a new type...
Contract Development and Manufacturing Organisation (CDMO) is a term for organizations providing extensive ...
Cystinosis is a genetic condition that causes the buildup of the amino acid "cystine" in the cells of the b...
HIV Therapeutics Market is expected to evolve owing to the launch of novel therapies and the active partici...
Diabetes, also known as diabetes mellitus, is one of the most serious and widespread public health concerns...
Hemophilia is an inherited rare disorder where blood doesn’t clot in the regular way because the person aff...
In the first half of 2021, leading pharma companies have launched more than 12+ therapies, which includes E...
HIV-1 Therapeutics Market is expected to grow with the entry of novel therapies and the R&D activities by k...
The United States (US) tops the global pharmaceutical industry and accounts for 46% of total global revenue...
With the advent of new-age healthcare industry trends that are evident as of now, there...
Although COVID-19 continued to dominate headlines in 2021, pharmaceutical companies did...
The Biosimilars market is growing at a breakneck pace. The biosimilar market provides a...
Chimeric antigen receptor T-cell (CAR T) therapies are shown to have transformative pot...
There has been limited progress in the approval of novel agents in MDS. It has been a l...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
